Kristina S.
- Country
- Sweden
- Department
- Center for Hematology
Research Overview
- Dose-Escalation and Expansion Study of BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein Degrader, in Patients with B-Cell Malignancies
- Evaluation of Adverse Events, Pharmacokinetics, and Disease Activity of Intravenous ABBV-291 in Adults With Non-Hodgkin's Lymphoma
- Efficacy and Safety of Golcadomide with R-CHOP Versus Placebo with R-CHOP in High-risk Large B-cell Lymphoma: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 140 of 343 partner sites.
Specializations
B-Cell Lymphoma Research
This investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on developing innovative therapeutic approaches for both newly diagnosed and relapsed cases.
- Relapsed and Refractory B-Cell Lymphoma
- Progressive B-Cell Malignancies
- High-risk Large B-cell Lymphoma
The investigator focuses on evaluating novel therapeutic agents and combinations for enhanced treatment outcomes in B-cell lymphoma patients.
Mantle Cell Lymphoma Studies
A significant portion of research is dedicated to advancing treatment protocols for Mantle Cell Lymphoma (MCL), particularly in elderly patient populations.
- Untreated MCL Management
- Rituximab-Based Combinations
- Novel Therapeutic Approaches
The research encompasses both conventional and innovative treatment strategies for managing MCL across different patient groups.
Diffuse Large B-Cell Lymphoma
The investigator conducts research in Diffuse Large B-Cell Lymphoma (DLBCL) treatment, focusing on improving standard therapeutic regimens.
- Newly Diagnosed DLBCL
- Combined Therapy Approaches
- Treatment Enhancement Strategies
Research efforts concentrate on evaluating enhanced treatment protocols and their impact on patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.